(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.09%) $0.927
(0.11%) $10.85
(-0.05%) $0.792
(-0.03%) $92.55
Quarter results today
(bmo 2024-03-29)
Expected move: +/- 7.50%
Live Chart Being Loaded With Signals
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata...
Stats | |
---|---|
Today's Volume | 52 238.00 |
Average Volume | 35 157.00 |
Market Cap | 25.34M |
EPS | $-0.260 ( 2023-11-13 ) |
Next earnings date | ( $0 ) 2024-03-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.700 |
ATR14 | $0.0100 (1.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Finck Barbara K | Buy | 175 000 | Stock Option (right to buy) |
2024-03-21 | Riley Antony A | Buy | 350 000 | Stock Option (right to buy) |
2024-03-21 | Wagner Paul A. | Buy | 1 100 000 | Stock Option (right to buy) |
2024-01-01 | Chen Hubert C | Buy | 7 500 | Common Stock |
2024-01-01 | Chen Hubert C | Sell | 3 073 | Common Stock |
INSIDER POWER |
---|
89.26 |
Last 93 transactions |
Buy: 4 737 754 | Sell: 316 977 |
Forte Biosciences, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Forte Biosciences, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-9 000.00 (0.00 %) |
EPS: | $-1.000 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-6 000.00 (0.00 %) |
EPS: | $-0.160 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-3 000.00 (0.00 %) |
EPS: | $-0.260 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.420 |
Financial Reports:
No articles found.
Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators